House Antidepressant Hearing To Feature Seven Companies, FDA's Woodcock
This article was originally published in The Pink Sheet Daily
Executive Summary
Sept. 9 hearing will also include a panel with representatives from PhRMA, AMA and the American Academy of Pediatrics.